Michael P. Dube, VP, Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA), sold 1,372 shares at $12.18 ($17K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $17k NTLA by VP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NTLA | SELL | 2026-01-07 | $28K | — | Filing → |
| NTLA | SELL | 2025-10-03 | $33K | — | Filing → |
| NTLA | SELL | 2025-07-03 | $25K | — | Filing → |